(28 days)
Not Found
No
The description focuses on the physical characteristics and intended use of a guide wire, with no mention of AI or ML capabilities.
No
The device is a guide wire, which is used to facilitate the delivery of other catheter-based interventional devices. While it may be used during therapeutic procedures, it does not directly provide a therapeutic effect itself.
No
This device is a guide wire, which is an interventional device used to facilitate the delivery of other catheter-based devices during therapeutic procedures. While it can "distinguish the vasculature," this is for navigation and pathway creation, not for forming a diagnostic opinion or image.
No
The device description clearly describes a physical guide wire with specific dimensions, materials (implied by "radiopaque length"), and mechanical properties ("steerable guide wires," "tip load"). This is a hardware medical device, not software.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly describes a device used in vivo (within the body) to facilitate interventional procedures in arteries. IVDs are used in vitro (outside the body) to examine specimens from the human body to provide information for diagnosis, monitoring, or screening.
- Device Description: The description details a physical guide wire designed to be inserted into blood vessels. This is consistent with an in vivo medical device, not an in vitro diagnostic test.
- Lack of IVD Characteristics: There is no mention of analyzing biological samples, reagents, or any other components typically associated with IVD devices.
Therefore, this guide wire is an interventional medical device used directly within the patient's body, not an IVD.
N/A
Intended Use / Indications for Use
This guide wire is intended to facilitate the delivery of catheter-based interventional devices during percutaneous transluminal angioplasty (PTA) in arteries such as the femoral, popliteal, and infrapopliteal arteries. This guide wire may be used with compatible stent devices during therapeutic procedures. The guide wire may be used to reach and cross a target lesion, provide a pathway within the vessel structure, facilitate the substitution of one diagnostic or interventional device for another, and to distinguish the vasculature.
Product codes
DQX
Device Description
The HI-TORQUE (HT) Proceed Guide Wire Family includes steerable guide wires offered in several tip load and guide wire length configurations.
The HT Proceed Guide Wire Family will be available with the features as listed below:
- 2 tip loads: 11g and 14g
- 1 coating length: Uncoated Tip ●
- 1 tip shape: Pre-shaped, micro-J ●
- 2 lengths: 190 cm, 300cm
The HT Proceed Guide Wires are designed to be compatible with devices designed for use with 0.014" guide wires. The HT Proceed Guide Wire Family has a maximum diameter of 0.0144". The distal tip has a radiopaque length of 3.0 cm.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
femoral, popliteal, and infrapopliteal arteries
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
The subject device is identical to the predicate device, HT InfilTrac, therefore in vitro bench testing and simulated use testing were leveraged from the predicate device to demonstrate that HT Proceed meets all acceptance criteria requirements as specified in the product specification and external guidance documents.
Results of these tests demonstrated that the HT InfilTrac Guide Wire Family (and, therefore, the HT Proceed Guide Wire) met the functional, dimensional and simulated use testing acceptance criteria requirements as specified in the product specification and external guidance documents. Based on the results, Abbott Vascular considers that the HT Proceed Guide Wire Family is substantially equivalent to the predicate device- HT InfilTrac Guide Wire.
Key Metrics
Not Found
Predicate Device(s)
HT InfilTrac (K193126)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.1330 Catheter guide wire.
(a)
Identification. A catheter guide wire is a coiled wire that is designed to fit inside a percutaneous catheter for the purpose of directing the catheter through a blood vessel.(b)
Classification. Class II (special controls). The device, when it is a torque device that is manually operated, non-patient contacting, and intended to manipulate non-cerebral vascular guide wires, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 870.9.
0
July 30, 2020
Image /page/0/Picture/1 description: The image shows the logos of the Department of Health & Human Services and the U.S. Food & Drug Administration (FDA). The Department of Health & Human Services logo is on the left, featuring a stylized human figure. The FDA logo is on the right, with the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue text. The logos are placed side by side.
Abbott Vascular Charlotte Pullman Specialist, Regulatory Affairs 3200 Lakeside Drive Santa Clara, California 95094
Re: K201834
Trade/Device Name: HI-TORQUE PROCEED Guide Wire Family Regulation Number: 21 CFR 870.1330 Regulation Name: Catheter Guide Wire Regulatory Class: Class II Product Code: DQX Dated: June 30, 2020 Received: July 2, 2020
Dear Charlotte Pullman:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for
1
devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device (https://www.fda.gov/medical-devices/ device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-andcontinuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatory-assistance/contact-usdivision-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely.
for Lydia Glaw, PhD. Assistant Director DHT2C: Division of Coronary and Peripheral Intervention Devices OHT2: Office of Cardiovascular Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K201834
Device Name HI-TORQUE PROCEED GUIDE WIRE
Indications for Use (Describe)
This guide wire is intended to facilitate the delivery of catheter-based interventional devices during percutaneous transluminal angioplasty (PTA) in arteries such as the femoral, popliteal, and infrapopliteal arteries. This guide wire may be used with compatible stent devices during therapeutic procedures. The guide wire may be used to reach and cross a target lesion, provide a pathway within the vessel structure, facilitate the substitution of one diagnostic or interventional device for another, and to distinguish the vasculature.
| Type of Use (Select one or both, as applicable) | |
|---|---|
| Prescription Use (Part 21 CFR 801 Subpart D) | Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
Image /page/3/Picture/0 description: The image shows the logo for Abbott, a healthcare company. The logo is a stylized letter 'A' in a light blue color. The 'A' is formed by thick, rounded lines, giving it a modern and clean look. The logo is simple and recognizable, representing the company's brand identity.
510(K) SUMMARY (K201834)
The 510(k) Summary is submitted in accordance with 21 CFR §807.92 and the requirements of the Safe Medical Device Act (SMDA) of 1990.
| | 1. Submitter's Name | Abbott Vascular
(with Business Trade Name as Abbott Medical) |
|--|-------------------------------|-----------------------------------------------------------------|
| | 2. Submitter's Address | 3200 Lakeside Dr., Santa Clara, CA 95054 |
| | 3. Telephone | 408-845-0652 |
| | 4. Fax | 408-845-3333 |
| | 5. Contact Person | Charlotte Pullman |
| | 6. Date Prepared | June 30, 2020 |
| | 7. Device Trade Name | HI-TORQUE PROCEED Guide Wire |
| | 8. Device Common Name | Guide Wire |
| | 9. Device Classification Name | Catheter Guide Wire (21 CFR 870.1330; Product Code -
DQX) |
| | 10. Predicate Device Name | HT InfilTrac (K193126, cleared on December 11, 2019) |
11. Device Description
The HI-TORQUE (HT) Proceed Guide Wire Family includes steerable guide wires offered in several tip load and guide wire length configurations.
The HT Proceed Guide Wire Family will be available with the features as listed below:
- 2 tip loads: 11g and 14g
- 1 coating length: Uncoated Tip ●
- 1 tip shape: Pre-shaped, micro-J ●
- 2 lengths: 190 cm, 300cm
The HT Proceed Guide Wires are designed to be compatible with devices designed for use with 0.014" guide wires. The HT Proceed Guide Wire Family has a maximum diameter of 0.0144". The distal tip has a radiopaque length of 3.0 cm.
4
Image /page/4/Picture/0 description: The image contains the logo for Abbott Vascular. The logo consists of a blue square with a white, stylized "A" inside. To the right of the logo is the text "Abbott Vascular" in a simple, sans-serif font.
12. Indication for Use
This guide wire is intended to facilitate the delivery of catheter-based interventional devices during percutaneous transluminal angioplasty (PTA) in arteries such as the femoral, popliteal, and infra-popliteal arteries. This guide wire may be used with compatible stent devices during therapeutic procedures. The guide wire may be used to reach and cross a target lesion, provide a pathway within the vessel structure, facilitate the substitution of one diagnostic or interventional device for another, and to distinguish the vasculature.
13. Technological Characteristics and Substantial Equivalence
The HT Proceed Guide Wire family (subject device) is technologically identical to the predicate device; both the subject and predicate devices use identical functional specifications, operating principle, materials, and design, and have an identical sterilization method, shelf life, and packaging components-materials.
The difference between the HT Proceed Guide Wire and its predicate device is the indication for use; the indication for use of the subject device is a subset of the indication for use of the originally cleared predicate device (HT InfilTrac, K193126, cleared December 11, 2019) and is not expanded outside of the currently cleared indication for the predicate device.
A comparison between the subject device and its predicate was performed to support a substantial equivalence determination. The substantial equivalence comparison included the device's indications for use, design, technological characteristics, materials, operating principle, sterilization, shelf life and packaging. The conclusion of the comparison analysis is that the subject device is substantially equivalent to the currently marketed predicate device.
14. Performance Data
The subject device is identical to the predicate device, HT InfilTrac, therefore in vitro bench testing and simulated use testing were leveraged from the predicate device to demonstrate that HT Proceed meets all acceptance criteria requirements as specified in the product specification and external guidance documents.
5
Image /page/5/Picture/0 description: The image contains the Abbott Vascular logo. The logo is a blue stylized letter A. To the right of the logo is the text "Abbott Vascular".
Results of these tests demonstrated that the HT InfilTrac Guide Wire Family (and, therefore, the HT Proceed Guide Wire) met the functional, dimensional and simulated use testing acceptance criteria requirements as specified in the product specification and external guidance documents. Based on the results, Abbott Vascular considers that the HT Proceed Guide Wire Family is substantially equivalent to the predicate device- HT InfilTrac Guide Wire.
15. Conclusions
The subject device is technologically identical to the predicate device, HT InfilTrac, and therefore test results from the performance testing conducted on the predicate device (HT InfilTrac, K193126) can be leveraged. The results demonstrated that the HT Proceed Guide Wire Family met all acceptance criteria requirements. Thus, Abbott Vascular considers the subject device - the Hi-Torque Proceed Guide Wire Family - to be substantially equivalent to the currently marketed predicate device - the HT InfilTrac Guide Wire.